A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
Why Joe Pompliano Will Be Watching the Grass on Super Bowl Sunday
Just days before the 49ers and Chiefs play in Las Vegas, Joe Pompliano, Investor at Pomp Investments and author of the Huddle Up Newsletter, discusses why he thinks this could be the most-watched Super Bowl in history.
Taking a ‘Well-Rounded’ Look at the Economy
Chris Versace of Tematica Research LLC shares his thoughts on Jerome Powell's latest comments, the timing of those crucial rate cuts, and what semiconductor stocks he's watching closely.
Sick of Influencers? Deinfluencers Offer a Minimalist Alternative
We battle an onslaught of advertising every time we scroll through social media. Deinfluencers propose a less pricey, more honest approach to how we shop online. Could they convince us to spend less?
Alto Neuroscience Wants to Revolutionize Mental Health Treatment
Fresh of its IPO at the NYSE, CEO of Alto Neuroscience Dr. Amit Etkin discusses how the company wants to innovate psychiatric medicine.
15 Lunar New Year Gifts to Ring in the Year of the Dragon
Don't let your Year of the Dragon gift search drag on. These products will help you celebrate the new year in style.
95% of Workers Plan to Look for a New Job in 2024 – Here’s Why
Scott Gutz, CEO of Monster.com breaks down the company’s Work Watch Report for 2024, including what’s motivating workers to look for new positions and why they should see A.I. as an opportunity.
January’s Blockbuster Jobs Report
Tom Graff, Chief Investment Officer, Facet, discusses what the latest jobs report says about this ‘pretty good’ labor market and why the market should worry less about the Fed’s next decision.
Your Favorite Songs Are No Longer on TikTok – Here's Why
Universal Music Group, which represents artists including Taylor Swift, Drake, and Ariana Grande, has removed its music from TikTok and accused the app of bullying and intimidation.
Firm Involved in Flint, Michigan Water Crisis Flushes Out $25M in Settlement
More than 45,000 Flint residents' claims will resolve from the class-action litigation agreement with Boston-based firm Veolia North America.
